Nonmalignant complications of Paget's disease

Journal of Bone and Mineral Research

Volumn 22, Issue SUPPL. 2, 2007, Pages

  Bone, Henry G ^a  

^a Michigan Bone and Mineral Clinic   (United States)

Author keywords

Osteitis deformans; Paget's disease of bone

Indexed keywords

ARTICLE; BINDING SITE; BONE REMODELING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOARCHITECTURE; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PAGET BONE DISEASE; POSTOPERATIVE COMPLICATION; STRUCTURE ACTIVITY RELATION; FRACTURE; HEARING LOSS; HEART DISEASE; REVIEW;

FRACTURES, BONE; HEARING LOSS; HEART DISEASES; HUMANS; NERVOUS SYSTEM DISEASES; OSTEITIS DEFORMANS;

EID: 34247866630     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.06S212     Document Type: Article

References (37)

1. Meunier PJ 2002 The pagetic lesion. Clin Rev Bone Miner Metab 1:103-107.
2. Cushing F, Bone HG 2002 Radiologic diagnosis and laboratory evaluation of Paget's disease of bone. Clin Rev Bone Miner Metab 1:115-134.
3. Kanis JA 1998 Pathophysiology and Treatment of Paget's Disease of Bone, 2nd ed. Martin Dunitz, London, UK.
4. McCloskey EV 2002 Neurological complications of Paget's disease. Clin Rev Bone Miner Metab 1:135-143.
5. Papapoulos S 2002 Pharmacological management of Paget's disease of bone. Clin Rev Bone Miner Metab 1:149-158.
6. Paget J 1877 On a form of chronic inflammation of bones (osteitis deformans). Med Chirurg Trans Lond 60:37-63.
7. Paget J 1882 Additional cases of osteitis deformans. Med Chirurg Trans Lond 65:225-236.
8. Paget J 1889 Remarks on osteitis deformans. Illustr Med News 2:181-182.
9. Briesacher BA, Orwig D, Seton M, Omar M, Kahler KH 2006 Medical care costs of Paget's disease of bone in a privately insured population. Bone 38:731-737.
10. Van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C 2002 Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 17:465-471.
11. Kristensen EB 1971 Ocular manifestations in Paget's disease (osteitis deformans). Report of a case with optic nerve involvement and ophthalmoplegia responding favourably to adrenocorticosteroid therapy. Acta Ophthalmol (Copenh) 49:741-746.
12. Schmidek HH 1977 Neurologic and neurosurgical sequelae of Paget's disease of bone. Clin Orthop 127:70-77.
13. Gardner WJ, Dohn DF 1966 Trigeminal neuralgia-hemifacial spasm-Paget's disease. Significance of this association. Brain 89:555-562.
14. Eretto P, Krohel GB, Shihab ZM, Wallach S, Hay P 1984 Optic neuropathy in Paget's disease. Am J Ophthalmol 97:505-510.
15. Wootton R, Reeve J, Spellacy E, Tellez-Yudilevich M 1978 Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy. Clin Sci Mol Med 54:69-74.
16. Douglas DL, Kanis JA, Duckworth T, Beard DJ, Paterson AD, Russell RG 1981 Paget's disease: Improvement of spinal cord dysfunction with diphosphonates and calcitonin. Metab Bone Dis Relat Res 3:327-335.
17. Douglas DL, Duckworth T, Kanis JA, Jefferson AA, Martin TJ, Russell RG 1981 Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? J Bone Joint Surg Br 63:495-503.
18. Chen J-R, Rhee RSC, Wallach S, Avramides A, Flores A 1979 Neurologic disturbances in Paget's disease of bone: Response to calcitonin. Neurology 29:448-457.
19. Charhon S, Chapuy MC, Valentin-Opran A, Meunier PJ 1982 Intravenous etidronate for spinal cord dysfunction due to Paget's disease. Lancet 1:391-392.
20. Monsell EM 2002 Emerging concept of hearing loss in Paget's disease of bone. Clin Rev Bone Miner Metab 1:145-147.
21. Monsell EM 2004 The mechanism of hearing loss in Paget's disease of bone. Laryngoscope 114:598-606.
22. Khetarpal U, Schuknecht HF 1990 In search of pathologic correlates for hearing loss and vertigo in Paget's disease. A clinical and histopathologic study of 26 temporal bones. Ann Otol Rhinol Laryngol Suppl 145:1-16.
23. Monsell EM, Bone HG, Cody DD, Jacobson GP, Newman CW, Patel SC, Divine GW 1995 Hearing loss in Paget's disease of bone: Evidence of auditory nerve integrity. Am J Otol 16:27-33.
24. Monsell EM, Cody DD, Bone HG 1993 Measurement of regional bone mineral density: A new technique for the evaluation of the temporal bone. Am J Otol 14:455-459.
25. Monsell EM, Cody DD, Bone HG, Divine GW 1999 Hearing loss as a complication of Paget's disease of bone. J Bone Miner Res 14:S2;92-95.
26. Bacciu A, Pasanisi E, Vincenti V, Ingegnoli F, Guida M, Panu F, Bacciu S 2004 Paget's disease and cochlear implantation. J Laryngol Otol 118:810-813.
27. Melton LJ III, Tiegs RD, Atkinson EJ, O'Fallon WM 2000 Fracture risk among patients with Paget's disease: A population-based cohort study. J Bone Miner Res 15:2123-2128.
28. Glaser DL, Kaplan FS 2002 Orthopedic surgery considerations in Paget's disease of bone. Clin Rev Bone Miner Metab 1:159-164.
29. Shardlow DL, Giannoudis PV, Matthews SJ, Smith RM 1999 Stabilisation of acute femoral fractures in Paget's disease. Int Orthop 23:283-285.
30. Cameron HU 1989 Total knee replacement in Paget's disease. Orthop Rev 18:206-208.
31. Hadjipavlou A, Lander P, Srolovitz H 1986 Pagetic arthritis. Pathophysiology and management. Clin Orthop Relat Res 208:15-19.
32. Lewallen DG 1999 Hip arthroplasty in patients with Paget's disease. Clin Orthop Relat Res 369:243-250.
33. Ludkowski P, Wilson-MacDonald J 1990 Total arthroplasty in Paget's disease of the hip. A clinical review and review of the literature. Clin Orthop Relat Res 255:160-167.
34. Morales-Piga AA, Moya JL, Bachiller FJ, Munoz-Malo MT, Benavides J, Abraira V 2000 Assessment of cardiac function by echocardiography in Paget's disease of bone. Clin Exp Rheumatol 18:31-37.
35. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE 2005 Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215-3224.
36. Kelly JJ, Moses AM 2006 Vitamin D deficiency and Paget's disease of bone. Paget's Disease of Bone/Fibrous Dysplasia: Advances and Challenges, January 12-14.2006, Ft. Lauderdale, FL, USA.
37. Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF 1993 Mineralisation defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1460.